Annals of Epidemiology
Volume 18, Issue 7 , Pages 560-571 , July 2008

Screening Young Adults for Prevalent Chlamydial Infection in Community Settings

  • Cheryl R. Stein, PhD

      Affiliations

    • Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
    • Corresponding Author InformationAddress correspondence to: Cheryl R. Stein, PhD, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1057, New York, NY 10029-6574. Tel.: 212-824-7083; fax: 212-996-0407.
  • ,
  • Jay S. Kaufman, PhD

      Affiliations

    • Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
  • ,
  • Carol A. Ford, MD

      Affiliations

    • Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill
  • ,
  • Peter A. Leone, MD

      Affiliations

    • Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill
  • ,
  • Paul J. Feldblum, PhD

      Affiliations

    • Clinical Research Division, Family Health International
  • ,
  • William C. Miller, MD, PhD, MPH

      Affiliations

    • Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
    • Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill

Received 25 September 2007 ,Accepted 14 March 2008.

References 

  1. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6–10
  2. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2005;
  3. Institute of Medicine (U.S.) . Committee on Prevention and Control of Sexually Transmitted Diseases., Eng TR, Butler WT. The hidden epidemic: Confronting sexually transmitted diseases. Washington, DC: National Academy Press; 1997;
  4. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;291:2229–2236
  5. Westrom L, Eschenbach D. Pelvic inflammatory disease. In:  Holmes KK editors. Sexually Transmitted Diseases. 3rd ed.. New York: McGraw-Hill Health Professions Division; 1999;p. 783–809
  6. Cates W, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991;164:1771–1781
  7. In:  Holmes KK editors. Sexually Transmitted Diseases. 3rd ed.. New York: McGraw-Hill Health Professions Division; 1999;
  8. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17
  9. Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet. 1998;351(Suppl 3):5–7
  10. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections. The impact of community-wide testing. Sex Transm Dis. 1997;24:169–175
  11. Hillis SD, Nakashima A, Amsterdam L, Pfister J, Vaughn M, Addiss D, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect. 1995;27:108–111
  12. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections—2002. MMWR Recomm Rep. 2002;51(RR-15):1–38quiz CE1–4
  13. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362–1366
  14. Screening for chlamydial infection: Recommendations and rationale. Am J Prev Med. 2001;20(3 Suppl):90–94
  15. Levine WC, Dicker LW, Devine O, Mosure DJ. Indirect estimation of Chlamydia screening coverage using public health surveillance data. Am J Epidemiol. 2004;160:91–96
  16. Tao G, Tian LH, Peterman TA. Estimating chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States. Sex Transm Dis. 2007;34:180–182
  17. Burstein GR, Snyder MH, Conley D, Newman DR, Walsh CM, Tao G, et al. Chlamydia screening in a Health Plan before and after a national performance measure introduction. Obstet Gynecol. 2005;106:327–334
  18. U.S. Department of Health and Human Services. Meeting Report: male chlamydia screening consultation. Atlanta, GA: Centers for Disease Control and Prevention; 2007;
  19. Stamm WE. Expanding efforts to prevent chlamydial infection. N Engl J Med. 1998;339:768–770
  20. Roberts TE, Robinson S, Barton P, Bryan S, Low N. Screening for Chlamydia trachomatis: A systematic review of the economic evaluations and modelling. Sex Transm Infect. 2006;82:193–200
  21. Bearman PS, Jones J, Udry JR. The National Longitudinal Study of Adolescent Health: study design. Chapel Hill, NC: Carolina Population Center, University of North Carolina at Chapel Hill, 2004. Available at: http://www.cpc.unc.edu/projects/addhealth/design. Accessed April 16, 2008.
  22. Resnick MD, Bearman PS, Blum RW, Bauman KE, Harris KM, Jones J, et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA. 1997;278:823–832
  23. The Add Health Biomarkers Team. Biomarkers in Wave III of the Add Health Study. Chapel Hill, NC: Carolina Population Center, University of North Carolina at Chapel Hill, 2004. Available at: http://www.cpc.unc.edu/projects/addhealth/files/biomark.pdf. Accessed April 16, 2008.
  24. Pugatch D, Ramratnam M, Strong L, Feller A, Levesque B, Dickinson BP. Gender Differences in HIV Risk behaviors among young adults and adolescents entering a massachusetts detoxification center. Subst Abus. 2000;21:79–86
  25. Ellen JM, Langer LM, Zimmerman RS, Cabral RJ, Fichtner R. The link between the use of crack cocaine and the sexually transmitted diseases of a clinic population. A comparison of adolescents with adults. Sex Transm Dis. 1996;23:511–516
  26. Trends in sexual risk behaviors among high school students—United States, 1991–2001. MMWR Morb Mortal Wkly Rep. 2002;51:856–859
  27. Burstein GR, Waterfield G, Joffe A, Zenilman JM, Quinn TC, Gaydos CA. Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex Transm Dis. 1998;25:395–402
  28. Harrell FE. Logistic Regression, and Survival Analysis. Regression Modeling Strategies: With Applications to Linear Models. New York: Springer; 2001;
  29. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44:837–845
  30. Hosmer DW, Lemeshow S, Byrns PJ. Applied Logistic Regression. New York: Wiley; 1989;
  31. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR Morb Mortal Wkly Rep. 1993;1993:42;(No. RR-12)
  32. Rietmeijer CA, Bull SS, Ortiz CG, Leroux T, Douglas JM. Patterns of general health care and STD services use among high-risk youth in Denver participating in community-based urine chlamydia screening. Sex Transm Dis. 1998;25:457–463
  33. Celum CL, Bolan G, Krone M, Code K, Leone P, Spaulding C, et al. Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis. 1997;24:599–605
  34. Geisler WM, Chyu L, Kusunoki Y, Upchurch DM, Hook EW. Health insurance coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in sexually active young adults. Sex Transm Dis. 2006;33:389–396
  35. Mills N, Daker-White G, Graham A, Campbell R. Population screening for Chlamydia trachomatis infection in the UK: a qualitative study of the experiences of those screened. Fam Pract. 2006;23:550–555
  36. Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: The need for new directions. Am J Public Health. 2007;97:125–132
  37. Plant AJ, Rushworth RL. “Death by proxy”: Ethics and classification in epidemiology. Soc Sci Med. 1998;47:1147–1153
  38. Manhart LE, Marrazzo JM, Fine DN, Kerani RP, Golden MR. Selective testing criteria for gonorrhea among young women screened for Chlamydial infection: Contribution of race and geographic prevalence. J Infect Dis. 2007;196:731–737
  39. Udry JR, Chantala K. Missing school dropouts in surveys does not bias risk estimates. Soc Sci Res. 2003;32:294–311
  40. Chantala K, Kalsbeek WD, Andraca E. Non-response in wave III of the Add Health study. Chapel Hill, NC: Carolina Population Center, University of North Carolina at Chapel Hill; 2004. Available at: http://www.cpc.unc.edu/projects/addhealth/files/W3nonres.pdf. Accessed April 16, 2008.
  41. Kurth AE, Martin DP, Golden MR, Weiss NS, Heagerty PJ, Spielberg F, et al. A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis. 2004;31:719–726
  42. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367–378
  43. Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152:99–106
  44. Murphy DA, Durako S, Muenz LR, Wilson CM. Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis. Am J Epidemiol. 2000;152:805–813
  45. Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867–873
  46. Ford CA, Jaccard J, Millstein SG, Miller WC. Who refuses to provide a urine specimen for Chlamydia trachomatis and Neisseria gonorrhoeae testing [abstract]?. J Adolesc Health. 2004;34:144

PII: S1047-2797(08)00057-4

doi: 10.1016/j.annepidem.2008.03.002

Annals of Epidemiology
Volume 18, Issue 7 , Pages 560-571 , July 2008